Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leishmaniasis, Visceral | 2 | 2021 | 100 | 0.760 |
Why?
|
Leprosy | 1 | 2021 | 125 | 0.720 |
Why?
|
Hemoglobins | 2 | 2022 | 1531 | 0.660 |
Why?
|
HIV Infections | 8 | 2023 | 17569 | 0.580 |
Why?
|
Health Services | 1 | 2021 | 755 | 0.530 |
Why?
|
Anemia | 2 | 2022 | 1514 | 0.520 |
Why?
|
Malaria | 2 | 2022 | 1249 | 0.510 |
Why?
|
Epidemics | 1 | 2020 | 517 | 0.450 |
Why?
|
Immunity | 1 | 2018 | 1003 | 0.410 |
Why?
|
Models, Theoretical | 2 | 2020 | 3573 | 0.360 |
Why?
|
Dog Diseases | 2 | 2021 | 143 | 0.350 |
Why?
|
Anti-Retroviral Agents | 1 | 2019 | 1789 | 0.340 |
Why?
|
Africa South of the Sahara | 2 | 2022 | 752 | 0.310 |
Why?
|
Soil | 1 | 2024 | 120 | 0.220 |
Why?
|
Helminthiasis | 1 | 2024 | 81 | 0.210 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5367 | 0.190 |
Why?
|
Leishmaniasis | 1 | 2021 | 67 | 0.190 |
Why?
|
Parasitemia | 1 | 2021 | 166 | 0.180 |
Why?
|
Markov Chains | 1 | 2024 | 979 | 0.180 |
Why?
|
Geography | 1 | 2021 | 652 | 0.160 |
Why?
|
Bangladesh | 1 | 2021 | 742 | 0.160 |
Why?
|
Asymptomatic Infections | 1 | 2018 | 136 | 0.150 |
Why?
|
Policy Making | 1 | 2021 | 546 | 0.150 |
Why?
|
Risk | 2 | 2021 | 9613 | 0.150 |
Why?
|
Geographic Information Systems | 1 | 2020 | 283 | 0.150 |
Why?
|
Financing, Government | 1 | 2021 | 473 | 0.140 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 500 | 0.140 |
Why?
|
Insecticides | 1 | 2018 | 200 | 0.140 |
Why?
|
HIV Seropositivity | 1 | 2022 | 966 | 0.140 |
Why?
|
Social Stigma | 1 | 2021 | 788 | 0.120 |
Why?
|
Incidence | 4 | 2021 | 21538 | 0.120 |
Why?
|
Prevalence | 5 | 2024 | 15869 | 0.110 |
Why?
|
Age Distribution | 1 | 2020 | 2873 | 0.110 |
Why?
|
Environment | 1 | 2020 | 1121 | 0.110 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2021 | 1903 | 0.110 |
Why?
|
Health Policy | 2 | 2023 | 2698 | 0.100 |
Why?
|
Antibodies, Viral | 1 | 2024 | 3216 | 0.100 |
Why?
|
India | 1 | 2018 | 2334 | 0.100 |
Why?
|
Vaccination | 1 | 2024 | 3437 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2018 | 2732 | 0.100 |
Why?
|
Adolescent Behavior | 1 | 2020 | 1186 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6847 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2507 | 0.090 |
Why?
|
Health Surveys | 1 | 2020 | 4057 | 0.080 |
Why?
|
Child | 4 | 2024 | 80917 | 0.080 |
Why?
|
Child, Preschool | 3 | 2022 | 42669 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5536 | 0.080 |
Why?
|
Models, Statistical | 2 | 2024 | 5107 | 0.080 |
Why?
|
Health Behavior | 1 | 2020 | 2650 | 0.080 |
Why?
|
Humans | 15 | 2024 | 768166 | 0.080 |
Why?
|
Life Style | 1 | 2020 | 3932 | 0.080 |
Why?
|
Poverty | 1 | 2018 | 2720 | 0.070 |
Why?
|
Dogs | 2 | 2021 | 3845 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7852 | 0.060 |
Why?
|
Risk Factors | 3 | 2022 | 74944 | 0.060 |
Why?
|
Public Health | 1 | 2018 | 2679 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5889 | 0.060 |
Why?
|
Adolescent | 4 | 2024 | 89169 | 0.060 |
Why?
|
Young Adult | 3 | 2022 | 60066 | 0.060 |
Why?
|
Helminths | 1 | 2024 | 39 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18412 | 0.050 |
Why?
|
Africa, Southern | 1 | 2022 | 60 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26379 | 0.050 |
Why?
|
Zimbabwe | 1 | 2022 | 135 | 0.050 |
Why?
|
Burkina Faso | 1 | 2021 | 88 | 0.050 |
Why?
|
Kenya | 1 | 2024 | 757 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 404 | 0.050 |
Why?
|
Infant | 2 | 2021 | 36535 | 0.040 |
Why?
|
France | 1 | 2021 | 497 | 0.040 |
Why?
|
Spain | 1 | 2021 | 485 | 0.040 |
Why?
|
Antibody Formation | 1 | 2024 | 1393 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 24315 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1250 | 0.030 |
Why?
|
Middle Aged | 3 | 2022 | 223492 | 0.030 |
Why?
|
Adult | 3 | 2022 | 223646 | 0.030 |
Why?
|
Family Characteristics | 1 | 2021 | 1003 | 0.030 |
Why?
|
Animals | 4 | 2024 | 169246 | 0.030 |
Why?
|
Workplace | 1 | 2022 | 873 | 0.030 |
Why?
|
Schools | 1 | 2024 | 1498 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2021 | 65371 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2022 | 1344 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4568 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2024 | 3080 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2021 | 81762 | 0.020 |
Why?
|
Male | 4 | 2022 | 364719 | 0.020 |
Why?
|
Female | 4 | 2022 | 397192 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5520 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2021 | 26422 | 0.010 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_